Current Edition


Merck drug for chronic cough rejected by FDA

Dive Brief: The Food and Drug Administration has rejected Merck & Co’s experimental drug for chronic cough, issuing the company a complete response letter for …

Continue Reading →

Medicare proposes to limit coverage of Biogen Alzheimer’s drug

Medicare will restrict coverage of Biogen’s controversial Alzheimer’s treatment only to patients who take part in a rigorous clinical trial, the federal government announced Tuesday, …

Continue Reading →

Nuance enters $58 M deal for non-opioid pain treatment in China

EXPAREL is a non-opioid option for achieving long-lasting pain control after surgery via infiltration into the surgical site or administration as an interscalene brachial plexus …

Continue Reading →

PATH, SD Biosensor partner to advance malaria treatment

PATH is advancing a portfolio of novel rapid tests for G6PD deficiency that are low cost, simple to use, and meet specifications to improve treatment …

Continue Reading →

Agendia, Angsana partner for cancer treatment in Southeast Asia

Partnership will enable women in Singapore, Malaysia, Vietnam, Brunei and Myanmar to access the benefits of MammaPrint® and BluePrint® to personalize treatment management decisions for …

Continue Reading →